Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if REPL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
33 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 56 days ago
Red flags: 14
199 filers reported a long position in REPL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | $122.3M | 11M | Unchanged |
| BlackRock, Inc. | $99.2M | 9M | +43.6% |
| RTW INVESTMENTS, LP | $82M | 7.4M | +0.7% |
| Ridgeback Capital Investments L.P. | $80.9M | 7.3M | — |
| GOLDMAN SACHS GROUP INC | $50.3M | 4.5M | +99.4% |
| STATE STREET CORP | $49.2M | 4.4M | +17.4% |
| MONTANOVA CAPITAL, LLC | $48.6M | 4.4M | +4% |
| Boxer Capital Management, LLC | $44.1M | 4M | +239% |
| VANGUARD CAPITAL MANAGEMENT LLC | $32.1M | 2.9M | +5% |
| FCPM III SERVICES B.V. | $31.1M | 2.8M | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.